Search

Your search keyword '"APPENDAGE CLOSURE DEVICE"' showing total 4 results
Start Over Descriptor "APPENDAGE CLOSURE DEVICE"
4 results on '"APPENDAGE CLOSURE DEVICE"'

1. Three-Dimensional Transesophageal Echocardiography in Percutaneous Catheter-Based Cardiac Interventions.

Author

Farina, Juan M., Barry, Timothy, Arsanjani, Reza, Ayoub, Chadi, and Naqvi, Tasneem Z.

Subjects
*TRANSESOPHAGEAL echocardiography, *HEART valve prosthesis implantation, *HEART valves, *SURGICAL & topographical anatomy
Abstract

Cardiac structural and valve interventions have remained surgical procedures for several decades. The ability to directly visualize the region of interest during surgery made imaging of these structures pre- and postsurgery a secondary tool to compliment surgical visualization. The last two decades, however, have seen rapid advances in catheter-based percutaneous structural heart interventions (SHIs). Due to the "blind" nature of these interventions, imaging plays a crucial role in the success of these procedures. Fluoroscopy is used universally in all percutaneous cardiac SHIs and helps primarily in the visualization of catheters and devices. However, success of these procedures requires visualization of intracardiac soft tissue structures. Due to its portable nature and rapid ability to show cardiac structures online, transesophageal echocardiography (TEE) has become an integral tool for guidance for all percutaneous SHI. Transcatheter aortic valve replacement—one of the earliest catheter-based procedures—while initially dependent on TEE, has largely been replaced by preprocedural cardiac CT for accurate assessment of valve sizing. Developments in echocardiography now allow live three-dimensional (3D) visualization of cardiac structures mimicking surgical anatomy during TEE. Besides showing actual 3D intracardiac structures, 3D-TEE allows visualization of the interaction of intracardiac catheters and devices with soft tissue cardiac structures, thereby becoming a "second pair of eyes" for the operator. Real-time 3D-TEE now plays an important role complementing multiplane two dimensional and biplane TEE during such interventions. In this review, we discuss the incremental role of 3D-TEE during various SHIs performed today. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

2. Hemostatic biomarkers and antithrombotic strategy in percutaneous left atrial interventions

Subjects
PHOSPHATIDYLSERINE EXPOSURE, PLATELET ACTIVATION, Patent/complications, Fibrinolytic Agents/pharmacology, Thromboembolism/drug therapy, ASD, Hemostatics, Thrombosis/complications, MEDICAL THERAPY, Septal Occluder Device/adverse effects, Anticoagulation, PROCOAGULANT ACTIVITY, PFO, Humans, Atrial Appendage/surgery, Retrospective Studies, Heart Diseases/complications, Hemostasis, Antiplatelet therapy, AMPLATZER CARDIAC PLUG, APPENDAGE CLOSURE DEVICE, THROMBUS FORMATION, Treatment Outcome, LAA closure, Cardiac Catheterization/adverse effects, SEPTAL-DEFECTS, PATENT FORAMEN OVALE, TRANSCATHETER CLOSURE, Atrial Fibrillation/complications, Biomarkers, Foramen Ovale
Abstract

Atrial septal defect, persistent foramen ovale and the left atrial appendage are nowadays often percutaneously closed with implantable devices. These interventions may be complicated by thromboembolic events and the perfect post-procedural antithrombotic management is still under investigation. The mechanisms leading to left atrial device-related thrombus and thromboembolic complications are not fully understood. Biomarkers of coagulation activation are elevated following percutaneous device placement, peaking within one month and returning to baseline values after three months. By contrast, platelet reactivity shows no post-procedural increase. This suggests that an optimal antithrombotic regimen should perhaps include (oral) anticoagulation therapy rather than the currently more frequently prescribed antiplatelet-based regimen. Furthermore, biomarkers of endothelial activation, fibrinolysis, and on-treatment platelet reactivity may be of value in predicting device-related thrombus and bleeding and guide future medical strategy, facilitating personalized medicine.

Published
2022

3. Hemostatic biomarkers and antithrombotic strategy in percutaneous left atrial interventions: State-of-the-art review

Author

Errol W. Aarnink, Marina F.M. Huijboom, Willem L. Bor, Moniek Maarse, Kai L. Zheng, Hugo Ten Cate, Jurriën M. Ten Berg, and Lucas V.A. Boersma

Subjects
PHOSPHATIDYLSERINE EXPOSURE, Cardiac Catheterization, Heart Diseases, Septal Occluder Device, PLATELET ACTIVATION, Patent/complications, Foramen Ovale, Patent, Fibrinolytic Agents/pharmacology, Thromboembolism/drug therapy, ASD, Hemostatics, Thrombosis/complications, MEDICAL THERAPY, Septal Occluder Device/adverse effects, Anticoagulation, PROCOAGULANT ACTIVITY, Fibrinolytic Agents, PFO, Thromboembolism, Atrial Fibrillation, Humans, Atrial Appendage, cardiovascular diseases, Atrial Appendage/surgery, PFO/ASD/LAA closure, Retrospective Studies, Heart Diseases/complications, Hemostasis, Antiplatelet therapy, Thrombosis, Hematology, AMPLATZER CARDIAC PLUG, APPENDAGE CLOSURE DEVICE, THROMBUS FORMATION, Treatment Outcome, LAA closure, Cardiac Catheterization/adverse effects, SEPTAL-DEFECTS, PATENT FORAMEN OVALE, TRANSCATHETER CLOSURE, Atrial Fibrillation/complications, Biomarkers, Foramen Ovale
Abstract

Atrial septal defect, persistent foramen ovale and the left atrial appendage are nowadays often percutaneously closed with implantable devices. These interventions may be complicated by thromboembolic events and the perfect post-procedural antithrombotic management is still under investigation. The mechanisms leading to left atrial device-related thrombus and thromboembolic complications are not fully understood. Biomarkers of coagulation activation are elevated following percutaneous device placement, peaking within one month and returning to baseline values after three months. By contrast, platelet reactivity shows no post-procedural increase. This suggests that an optimal antithrombotic regimen should perhaps include (oral) anticoagulation therapy rather than the currently more frequently prescribed antiplatelet-based regimen. Furthermore, biomarkers of endothelial activation, fibrinolysis, and on-treatment platelet reactivity may be of value in predicting device-related thrombus and bleeding and guide future medical strategy, facilitating personalized medicine.

Published
2022

4. EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation

Author

Donal, Erwan, Lip, Gregory Y H, Galderisi, Maurizio, Goette, Andreas, Shah, Dipen, Marwan, Mohamed, Lederlin, Mathieu, Mondillo, Sergio, Edvardsen, Thor, Sitges, Marta, Grapsa, Julia, Garbi, Madalina, Senior, Roxy, Gimelli, Alessia, Potpara, Tatjana S, Van Gelder, Isabelle C, Gorenek, Bulent, Mabo, Philippe, Lancellotti, Patrizio, Kuck, Karl-Heinz, Popescu, Bogdan A, Hindricks, Gerhard, Habib, Gilbert, Cardim, Nuno M, Cosyns, Bernard, Delgado, Victoria, Haugaa, Kristina H, Muraru, Denisa, Nieman, Koen, Boriani, Giuseppe, Cohen, Ariel, Clinical sciences, Cardio-vascular diseases, Cardiology, CIC-IT Rennes, Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), University of Naples Federico II = Università degli studi di Napoli Federico II, Cardiology Department, Thorax Clinic Institute, Hospital Cliınic, Institut d'Investigacions Biomèdiques [Barcelona], Universitat de Barcelona (UB), Imperial College London, Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes], CHU Pontchaillou [Rennes], Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA-Research), Université de Liège, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS), Service de cardiologie, Université de la Méditerranée - Aix-Marseille 2-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Donal, E, Lip, G, Galderisi, M, Goette, A, Shah, D, Marwan, M, Lederlin, M, Mondillo, S, Edvardsen, T, Sitges, M, Grapsa, J, Garbi, M, Senior, R, Gimelli, A, Potpara, T, Van Gelder, I, Gorenek, B, Mabo, P, Lancellotti, P, Kuck, K, Popescu, B, Hindricks, G, Habib, Document Reviewers: Cardim NM, G, Cosyns, B, Delgado, V, Haugaa, K, Muraru, D, Nieman, K, Boriani, G, Cohen, A, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Università degli studi di Napoli Federico II, INSB-INSB-Centre National de la Recherche Scientifique (CNRS), Donal, Erwan, Lip, Gregory Y. H, Galderisi, Maurizio, Goette, Andrea, Shah, Dipen, Marwan, Mohamed, Lederlin, Mathieu, Mondillo, Sergio, Edvardsen, Thor, Sitges, Marta, Grapsa, Julia, Garbi, Madalina, Senior, Roxy, Gimelli, Alessia, Potpara, Tatjana S, Van Gelder, Isabelle C, Gorenek, Bulent, Mabo, Philippe, Lancellotti, Patrizio, Kuck, Karl Heinz, Popescu, Bogdan A, Hindricks, Gerhard, and Habib, Gilbert

Subjects
Cardiac magnetic resonance, RIGHT-VENTRICULAR FUNCTION, Speckle tracking echocardiography, Computed tomography, 030204 cardiovascular system & hematology, Doppler echocardiography, Multimodal Imaging, 0302 clinical medicine, Nuclear Medicine and Imaging, RADIOFREQUENCY CATHETER ABLATION, 030212 general & internal medicine, Cardiac imaging, ddc:616, SPONTANEOUS ECHOCARDIOGRAPHIC CONTRAST, medicine.diagnostic_test, CARDIAC MAGNETIC-RESONANCE, Atrial fibrillation, General Medicine, Atrial Fibrillation/diagnostic imaging/epidemiology/physiopathology, Pathophysiology, Atrial Fibrillation, Consensus, Europe, Humans, Practice Guidelines as Topic, Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine, 3. Good health, MULTISLICE COMPUTED-TOMOGRAPHY, Cardiology, cardiovascular system, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Atrial Fibrillation/diagnostic imaging, Radiology, Human, TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY, medicine.medical_specialty, SPECKLE-TRACKING ECHOCARDIOGRAPHY, SPONTANEOUS ECHO CONTRAST, Consensu, Multi modality, 03 medical and health sciences, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, business.industry, HEART RHYTHM ASSOCIATION, Expert consensus, medicine.disease, APPENDAGE CLOSURE DEVICE, business
Abstract

International audience; Atrial fibrillation (AF) is the commonest cardiac rhythm disorder. Evaluation of patients with AF requires an electrocardiogram, but imaging techniques should be considered for defining management and driving treatment. The present document is an expert consensus from the European Association of Cardiovascular Imaging (EACVI) and the European Heart Rhythm Association. The clinical value of echocardiography, cardiac magnetic resonance (CMR), computed tomography (CT), and nuclear imaging in AF patients are challenged. Left atrial (LA) volume and strain in echocardiography as well as assessment of LA fibrosis in CMR are discussed. The value of CT, especially in planning interventions, is highlighted. Fourteen consensus statements have been reached. These may serve as a guide for both imagers and electrophysiologists for best selecting the imaging technique and for best interpreting its results in AF patients

Published
2016

Catalog

Books, media, physical & digital resources
See catalog results